Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
9/30/2025 | $ 522.47M | $ 79.41M | $ 443.07M | $ 0 |
6/30/2025 | $ 591.55M | $ 85.16M | $ 506.39M | $ 0 |
3/31/2025 | $ 615.04M | $ 76.82M | $ 538.23M | $ 0 |
12/31/2024 | $ 669.34M | $ 110.9M | $ 558.45M | $ 0 |
9/30/2024 | $ 513.6M | $ 99.94M | $ 413.65M | $ 0 |
6/30/2024 | $ 511.03M | $ 117.69M | $ 393.34M | $ 0 |
3/31/2024 | $ 312.67M | $ 50.71M | $ 261.96M | $ 0 |
12/31/2023 | $ 355.6M | $ 55.53M | $ 300.07M | $ 0 |
9/30/2023 | $ 308.19M | $ 43.2M | $ 264.99M | $ 0 |
6/30/2023 | $ 350.62M | $ 59.86M | $ 290.76M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for NURIX THERAPEUTICS INC is calculated as follows: Assets [ $ 396.34M ] - Intangibles [ $ 0 ] - CashnEq [ $ 119.53M ]
(=) Core Assets [ $ 276.82M ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.36B |
average | $ 798.36M |
median | $ 287.51M |
std | $ 1.05B |